VAM
Visium Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1 |
|
|
2016
Q2 | – | Sell |
-52,700
| Closed | -$1.47M | – | 291 |
|
|
2016
Q1 | $1.47M | Sell |
52,700
-814,417
| -94% | -$22.8M | 0.03% | 380 |
|
|
2015
Q4 | $30.9M | Buy |
867,117
+5,697
| +0.7% | +$203K | 0.46% | 39 |
|
|
2015
Q3 | $28.5M | Buy |
861,420
+25,098
| +3% | +$830K | 0.39% | 48 |
|
|
2015
Q2 | $35M | Buy |
+836,322
| New | +$35M | 0.5% | 36 |
|
|
2014
Q2 | – | Sell |
-227,936
| Closed | -$5.55M | – | 1002 |
|
|
2014
Q1 | $5.55M | Sell |
227,936
-878,686
| -79% | -$21.4M | 0.09% | 203 |
|
|
2013
Q4 | $27.7M | Sell |
1,106,622
-140,587
| -11% | -$3.51M | 0.54% | 38 |
|
|
2013
Q3 | $34.3M | Sell |
1,247,209
-780,578
| -38% | -$21.4M | 0.78% | 25 |
|
|
2013
Q2 | $36.8M | Buy |
+2,027,787
| New | +$36.8M | 0.86% | 24 |
|